MarketPeel
Insider Trading Intelligence
YN

Yousha Neman-ebrahim

NTHI
CHIEF CLINICAL OFFICER · NEONC TECHNOLOGIES HOLDINGS, INC. · CIK 0002071642
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$9.8K
COMPANIES
1
ACTIVE SINCE
Jun 2025
HOLDINGS NOW
134,760
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yousha Neman-ebrahim, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+18.44%+2.80%+15.64%+15.64%
14d2+100.00%+46.58%+4.07%+42.51%+42.51%
30d2+100.00%+14.85%+4.30%+13.91%+13.91%
60d2+100.00%+25.50%+4.62%+20.88%+20.88%
90d2(1 pending)+100.00%+51.43%+5.17%+46.26%+46.26%
180d2(1 pending)+0.00%-7.08%+13.76%-20.84%-20.84%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NTHI · 134,760 shares · as of Apr 23, 2026
033,69067,380101,070134,7602026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
2026
FLOW · 4 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
PURCHASE
Chief Clinical Officer
500$4.88$2.4K134,760Apr 23, 2026Apr 24, 2026View →
NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
PURCHASE
Chief Clinical Officer
1,100$6.69$7.4K134,260Nov 20, 2025Nov 24, 2025View →
NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
PURCHASEGRANT
Stock grant
67,00067,000Jun 5, 2025Jun 9, 2025View →
NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
PURCHASEGRANT
Stock grant
133,000133,000Jun 5, 2025Jun 9, 2025View →
Other insiders · NTHI
Loading peer insiders…
About this filer
CIK 0002071642
ROLE
Chief Clinical Officer
PRIMARY
NTHI
COMPANIES
1
ACTIVE SINCE
Jun 2025
MARKETPEEL · /INSIDER/0002071642DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback